West Family Investments Inc. purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the second quarter, Holdings Channel reports. The fund purchased 4,680 shares of the medical research company’s stock, valued at approximately $622,000.
Several other institutional investors have also bought and sold shares of the stock. Knuff & Co LLC bought a new position in Agilent Technologies in the 2nd quarter valued at about $203,000. NewEdge Wealth LLC acquired a new position in shares of Agilent Technologies during the second quarter valued at approximately $668,000. Great Lakes Advisors LLC bought a new stake in Agilent Technologies during the second quarter worth approximately $297,000. Danske Bank A S bought a new stake in Agilent Technologies during the second quarter worth approximately $32,556,000. Finally, Diversify Advisory Services LLC acquired a new stake in Agilent Technologies in the second quarter worth approximately $446,000.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on A shares. Sanford C. Bernstein started coverage on Agilent Technologies in a research note on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective on the stock. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. HSBC decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Robert W. Baird increased their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Finally, Barclays increased their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.
Agilent Technologies Trading Up 4.7%
NYSE A opened at $155.40 on Thursday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The firm’s fifty day simple moving average is $136.44 and its 200-day simple moving average is $125.84. The company has a market capitalization of $43.89 billion, a PE ratio of 31.20, a price-to-earnings-growth ratio of 2.63 and a beta of 1.25.
Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter last year, the firm earned $1.31 earnings per share. The business’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More
- Five stocks we like better than Agilent Technologies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
